StockData
InfuSystem Holdings, Inc logo

InfuSystem Holdings, Inc (INFU) income statement

INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 13/303% above fair value
$14.67−0.12 (-0.81%)

Close on Nov 18, 2026Market cap $292.19MP/E 35.8Yield –

InfuSystem Holdings, Inc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
57.5%
Operating margin
9.3%
Net margin
6.0%
Return on equity, FY2025
11.5%

Financial strength

Current ratio
2.50
Debt to equity
0.35
Debt to assets
20.9%
Cash to current liabilities
6.3%

Valuation

P/E ratio
35.8
Price to sales
2.04
Price to book
4.94
Dividend yield
–

See a number that looks wrong?